International Clinical Trial: Safety and Efficacy of The iLet Bionic Pancreas System (algorithm 2.0), a new automated insulin delivery (AID) system, in people with type 1 diabetes

Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ACTRN12625000451404) titled 'Safety and Efficacy of The iLet Bionic Pancreas System (algorithm 2.0), a new automated insulin delivery (AID) system, in people with type 1 diabetes' on May 13.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Randomised controlled trial Masking: Open (masking not used) Assignment: Other

Primary Sponsor: University of Otago, Christchurch.

Condition: Type 1 diabetes Type 1 diabetes Metabolic and Endocrine - Diabetes

Intervention: Automated insulin delivery (AID) is a new therapy that aims to improve outcomes for people with diabetes. AID links an insulin pump and continuous glucos...